March 7, 2019
Using Selection Biomarkers and Unraveling the Resulting Data to Drive Clinical Trial SuccessRead more...
March 5, 2019
Precision for Medicine Acquires Industry-leading Artificial Intelligence Technology, Significantly E...Discover more...
December 17, 2018
Precision Medicine Group Acquires Stern Investor Relations, Inc.Get the story...
Precision for Medicine can help you find and extract the long-term value of innovative drugs
We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. And we’re constantly adding services and expertise under that roof to support medical innovators — like our recent acquisition of ETHOS Health Communications, specializing in the interpretation and communication of medical science. In short: Precision dramatically accelerates your pathway from proof of concept to drug approval.